AI assistant
BIO-TECHNE Corp — Director's Dealing 2024
Feb 5, 2024
30718_dirs_2024-02-05_425d4dd5-eb43-460a-81f7-5b0768cd358e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-11-01
Reporting Person: Kelderman Kim (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-01 | Restricted Stock Units | $ | A | 9423 | Acquired | Common Stock (9423) | Direct | |
| 2024-02-01 | Stock Options (Right to Buy) | $68.54 | A | 25945 | Acquired | 2031-02-01 | Common Stock (25945) | Direct |
| 2024-02-01 | Stock Options (Right to Buy) | $68.54 | A | 51890 | Acquired | 2031-02-01 | Common Stock (51890) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 35421 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $37.70 | 2025-05-01 | Common Stock (27392) | 27392 | Direct |
| Stock Option (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (84308) | 84308 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (109536) | 109536 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (69264) | 69264 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (47952) | 47952 | Direct |
| Restricted Stock Units | $ | Common Stock (4980) | 4980 | Direct | |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (19456) | 19456 | Direct |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common stock (25944) | 25944 | Direct |
| Restricted Stock Units | $ | Common Stock (6984) | 6984 | Direct | |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (21704) | 21704 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (28940) | 28940 | Direct |
| Restricted Stock Units | $ | Common Stock (8873) | 8873 | Direct | |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (23881) | 23881 | Direct |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (29391) | 29391 | Direct |
| Stock Options (Right to Buy) | $52.83 | 2030-11-01 | Common Stock (38252) | 38252 | Direct |
Footnotes
F1: Fully exercisable.
F2: Options to purchase 35,964 shares are vested. Options to purchase 11,988 shares vest on 8/5/2024.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
F6: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 7,236 shares are vested. Options to purchase 7,236 shares vest on each of 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
F8: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
F10: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
F11: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.